These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 38292634)
1. Gut-targeted therapies for type 2 diabetes mellitus: A review. Xu TC; Liu Y; Yu Z; Xu B World J Clin Cases; 2024 Jan; 12(1):1-8. PubMed ID: 38292634 [TBL] [Abstract][Full Text] [Related]
2. The Role of Fecal Microbiota Transplantation (FMT) in the Management of Metabolic Diseases in Humans: A Narrative Review. Zikou E; Koliaki C; Makrilakis K Biomedicines; 2024 Aug; 12(8):. PubMed ID: 39200335 [TBL] [Abstract][Full Text] [Related]
3. Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus. Wu J; Yang K; Fan H; Wei M; Xiong Q Front Endocrinol (Lausanne); 2023; 14():1114424. PubMed ID: 37229456 [TBL] [Abstract][Full Text] [Related]
4. Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus. Zhou Z; Sun B; Yu D; Zhu C Front Cell Infect Microbiol; 2022; 12():834485. PubMed ID: 35242721 [TBL] [Abstract][Full Text] [Related]
5. The role of the gut microbiome in colonization resistance and recurrent Seekatz AM; Safdar N; Khanna S Therap Adv Gastroenterol; 2022; 15():17562848221134396. PubMed ID: 36425405 [TBL] [Abstract][Full Text] [Related]
6. Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review. Li HY; Zhou DD; Gan RY; Huang SY; Zhao CN; Shang A; Xu XY; Li HB Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579087 [TBL] [Abstract][Full Text] [Related]
7. Gut microbiota-derived metabolites as key actors in type 2 diabetes mellitus. Du L; Li Q; Yi H; Kuang T; Tang Y; Fan G Biomed Pharmacother; 2022 May; 149():112839. PubMed ID: 35325852 [TBL] [Abstract][Full Text] [Related]
8. Role of Synbiotics (Prebiotics and Probiotics) as Dietary Supplements in Type 2 Diabetes Mellitus Induced Health Complications. Baghel K; Khan A; Kango N J Diet Suppl; 2024; 21(5):677-708. PubMed ID: 38622882 [TBL] [Abstract][Full Text] [Related]
9. From role of gut microbiota to microbial-based therapies in type 2-diabetes. Ebrahimzadeh Leylabadlo H; Sanaie S; Sadeghpour Heravi F; Ahmadian Z; Ghotaslou R Infect Genet Evol; 2020 Jul; 81():104268. PubMed ID: 32126303 [TBL] [Abstract][Full Text] [Related]
10. The relationship between gut microbiota and susceptibility to type 2 diabetes mellitus in rats. An Y; Dai H; Duan Y; Cheng L; Shi L; He C; Wang C; Lv Y; Li H; Zhang H; Huang Y; Fu W; Sun W; Zhao B Chin Med; 2023 May; 18(1):49. PubMed ID: 37147692 [TBL] [Abstract][Full Text] [Related]
11. Gut microbiome supplementation as therapy for metabolic syndrome. Antony MA; Chowdhury A; Edem D; Raj R; Nain P; Joglekar M; Verma V; Kant R World J Diabetes; 2023 Oct; 14(10):1502-1513. PubMed ID: 37970133 [TBL] [Abstract][Full Text] [Related]
12. GUT MICROBIOTA, PREBIOTICS, PROBIOTICS, AND SYNBIOTICS IN MANAGEMENT OF OBESITY AND PREDIABETES: REVIEW OF RANDOMIZED CONTROLLED TRIALS. Barengolts E Endocr Pract; 2016 Oct; 22(10):1224-1234. PubMed ID: 27409822 [TBL] [Abstract][Full Text] [Related]
13. Microbiota shaping - the effects of probiotics, prebiotics, and fecal microbiota transplant on cognitive functions: A systematic review. Baldi S; Mundula T; Nannini G; Amedei A World J Gastroenterol; 2021 Oct; 27(39):6715-6732. PubMed ID: 34754163 [TBL] [Abstract][Full Text] [Related]
14. Probiotics, prebiotics, synbiotics and insulin sensitivity. Kim YA; Keogh JB; Clifton PM Nutr Res Rev; 2018 Jun; 31(1):35-51. PubMed ID: 29037268 [TBL] [Abstract][Full Text] [Related]
15. The Prospect for Type 2 Diabetes Mellitus Combined with Exercise and Synbiotics: A Perspective. Dewi L; Rosidi A; Noer ER; Ayuningtyas A Curr Diabetes Rev; 2021; 17(8):e012821190875. PubMed ID: 33511948 [TBL] [Abstract][Full Text] [Related]
16. Probiotics, prebiotics, and synbiotics added to dairy products: Uses and applications to manage type 2 diabetes. Zepeda-Hernández A; Garcia-Amezquita LE; Requena T; García-Cayuela T Food Res Int; 2021 Apr; 142():110208. PubMed ID: 33773683 [TBL] [Abstract][Full Text] [Related]
17. Probiotics, Prebiotics, Synbiotics, Postbiotics, and Obesity: Current Evidence, Controversies, and Perspectives. Vallianou N; Stratigou T; Christodoulatos GS; Tsigalou C; Dalamaga M Curr Obes Rep; 2020 Sep; 9(3):179-192. PubMed ID: 32472285 [TBL] [Abstract][Full Text] [Related]
18. Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile). Minkoff NZ; Aslam S; Medina M; Tanner-Smith EE; Zackular JP; Acra S; Nicholson MR; Imdad A Cochrane Database Syst Rev; 2023 Apr; 4(4):CD013871. PubMed ID: 37096495 [TBL] [Abstract][Full Text] [Related]
19. Faecal microbiota transplantation is better than probiotics for tissue regeneration of type 2 diabetes mellitus injuries in mice. Wang Y; Yang Z; Tang H; Sun X; Qu J; Lu S; Rao B Arch Physiol Biochem; 2024 Jun; 130(3):333-341. PubMed ID: 35675471 [TBL] [Abstract][Full Text] [Related]
20. Understanding how pre- and probiotics affect the gut microbiome and metabolic health. Bock PM; Martins AF; Schaan BD Am J Physiol Endocrinol Metab; 2024 Jul; 327(1):E89-E102. PubMed ID: 38809510 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]